➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Merck
Colorcon
Johnson and Johnson
Medtronic

Last Updated: January 24, 2021

DrugPatentWatch Database Preview

Litigation Details for AUXILIUM PHARMACEUTICALS, INC. v. WATSON LABORATORIES, INC. (NV) (D.N.J. 2012)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in AUXILIUM PHARMACEUTICALS, INC. v. WATSON LABORATORIES, INC. (NV)
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for AUXILIUM PHARMACEUTICALS, INC. v. WATSON LABORATORIES, INC. (NV) (D.N.J. 2012)

Date Filed Document No. Description Snippet Link To Document
2014-09-14 269 as to United States Patent No. 7,320,968, # 2 Stipulation as to United States Patent Nos. 7,608,605, 7,… 26 February 2015 2:12-cv-03084 830 Patent Defendant District Court, D. External link to document
2014-09-16 272 of WATSON LABORATORIES, INC. as to U.S. Patent No. 7,320,968. Signed by Judge Jose L. Linares on 9/15… 26 February 2015 2:12-cv-03084 830 Patent Defendant District Court, D. External link to document
2014-09-16 273 #275] STIPULATION AND ORDER as to U.S. Patent Nos. 7,608,605; 7,608,606; 7,608,608; 7,608,609; and 8,… 26 February 2015 2:12-cv-03084 830 Patent Defendant District Court, D. External link to document
2014-09-23 276 STIPULATION AND ORDER as to U.S. PATENT NOS. 7,608,605; 7,608,606; 7,608,608; 7,608,609; and 8,… 26 February 2015 2:12-cv-03084 830 Patent Defendant District Court, D. External link to document
2014-10-30 292 STIPULATION AND ORDER as to U.S. PATENT NOS. 7,608,605; 7,608,606; 7,608,607; 7,608,608; 7,608,… 26 February 2015 2:12-cv-03084 830 Patent Defendant District Court, D. External link to document
2014-12-16 298 , inter alia, U.S. Patent No. 6,503,894 (“the ’894 Dudley patent”), U.S. Patent Nos. 5,023,252 and …the ’968 patent, the examiner considered and reviewed, inter alia, U.S. Patent No. 6,503,894 (“the ’…the ’968 patent, the examiner considered and reviewed, inter alia, U.S. Patent No. 6,503,894 (“the ’894…AndroGel® and the ’894 “Dudley” Patent U.S. Patent No. 6,503,894, issued to Robert Dudley et al…the ’607 patent, the ’610 patent, the ’690 patent, and the ’029 patent (“asserted patents”). External link to document
2015-02-25 306 Claim 3 of U.S. Patent No. 7,608,607 (D.I. 261; Claim 3 of U.S. Patent No. 7,608,607 is invalid for obviousness…derivation, and improper inventorship; U.S. Patent No. 7,608,607 is not unenforceable due to inequitable … 26 February 2015 2:12-cv-03084 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
McKesson
Johnson and Johnson
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.